Did the Eagles Put Jalen Hurts at Risk? Their Blood Clot Timeline Demands Answers

Writer Gary Adornato argues that the Philadelphia Eagles owe the public a fuller explanation regarding their medical handling of quarterback Jalen Hurts. The Eagles cleared Hurts to play against the Jacksonville Jaguars on October 11 despite knowing about a diagnosed superficial blood clot, before later announcing he developed deep vein thrombosis and bilateral pulmonary emboli.

Adornato highlights questions surrounding Hurts' late-night London hospital visit and the decision to permit full-contact play based on general mobility recommendations. While the writer stresses that subsequent diagnoses do not prove malpractice, he contends an independent review is warranted to clarify the clinical basis of Philadelphia's decisions.